Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Equity Ratio (2020 - 2025)

Journey Medical's Equity Ratio history spans 6 years, with the latest figure at 0.34 for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 34.64% year-over-year to 0.34, compared with a TTM value of 0.34 through Dec 2025, up 34.64%, and an annual FY2025 reading of 0.34, up 34.64% over the prior year.
  • Equity Ratio for Q4 2025 was 0.34 at Journey Medical, up from 0.3 in the prior quarter.
  • The five-year high for Equity Ratio was 0.43 in Q4 2021, with the low at 0.13 in Q3 2021.
  • Average Equity Ratio over 5 years is 0.22, with a median of 0.25 recorded in 2022.
  • Year-over-year, Equity Ratio plummeted 99.98% in 2023 and then skyrocketed 241594.88% in 2024.
  • Tracing DERM's Equity Ratio over 5 years: stood at 0.43 in 2021, then plummeted by 62.63% to 0.16 in 2022, then skyrocketed by 63.98% to 0.26 in 2023, then decreased by 5.55% to 0.25 in 2024, then skyrocketed by 34.64% to 0.34 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Equity Ratio are 0.34 (Q4 2025), 0.3 (Q3 2025), and 0.24 (Q2 2025).